Quantcast

Latest Multi-drug-resistant tuberculosis Stories

2014-02-13 08:30:51

MOSCOW, February 13, 2014 /PRNewswire/ -- Russian and Korean biotech companies Infectex Ltd. [http://www.infectex.ru/?ln=en ] and Qurient Ltd. [http://maxwellbiotech.com ] have announced a license agreement granting Infectex exclusive rights to develop and commercialize Qurient's Tuberculosis-fighting drug Q203 in the Russian Federation, Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan and Ukraine. (Logo:...

2014-01-28 23:04:15

Aim to Improve Care for HIV Patients in Irkutsk, Halt Growing Health Threat Charlottesville, VA (PRWEB) January 28, 2014 Researchers at the University of Virginia School of Medicine and colleagues in Russia are launching an ambitious effort to check the growing public health threat posed by drug-resistant tuberculosis, especially to people with HIV, in the Siberian city of Irkutsk. It’s a critically important mission, both for the people there and because of the risk that international...

2014-01-27 23:02:49

Research led by St. Jude Children’s Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance Memphis, TN (PRWEB) January 27, 2014 St. Jude Children’s Research Hospital scientists have discovered a promising new class of antibiotics that could aid efforts to overcome drug-resistance in tuberculosis (TB), a global killer. The drugs increased survival of mice...

2013-10-31 23:34:25

Immunitor, Inc., a commercial stage company committed to developing oral therapeutic vaccines, today announced that its second Phase II trial of oral TB vaccine with heat-killed Mycobacterium vaccae (V7) was published in October issue of Immunotherapy journal. Vancouver, BC, Canada (PRWEB) October 31, 2013 This study is second of two Phase II trials run by Immunitor in Ukraine. The trial was conducted in 41 patients with pulmonary tuberculosis randomized into treatment (N=20) and placebo...

2013-10-23 23:20:34

Lauds Reduction in New Infections and Lowered Mortality Rate of TB; Urges More Aggressive Identification of Nearly 3 Million “Missed” New Cases of TB Annually and Greater Focus on More Virulent Strains of TB to Avert Public Health Crisis New York, NY (PRWEB) October 23, 2013 Today, the World Health Organization (WHO) released its Global Tuberculosis Report 2013. Ray Chambers, the UN Secretary-General’s Special Envoy for Financing the Health MDGs and for Malaria, acknowledged both...

2013-09-23 23:32:49

Immunitor company announces publication of a successful clinical trial in 43 patients with tuberculosis who were given daily pill of therapeutic vaccine containing heat-killed Mycobacterium vaccae. The study, which is the first installment of two-part study, was published in September issue of Human Vaccines & Immunotherapeutics journal. Vancouver, BC, Canada (PRWEB) September 23, 2013 One-month Phase II trial was conducted in sputum smear-positive patients with pulmonary tuberculosis...

2013-09-09 08:46:15

Virtual observation of patients taking their prescribed TB medication, could prove an effective technique for ensuring patients effectively complete their course of treatment. The research will be presented today (8 September 2013) at the European Respiratory Society (ERS) Annual Congress. The new study suggests an alternative method to directly observed treatment (DOT), which is recommended by the World Health Organization. Directly observing treatments is often time consuming for a...

2013-09-09 08:42:31

Results of a new study suggest that three new diagnostic tests could each be used to successfully diagnose drug resistance in tuberculosis (TB) patients in a quarter of the time taken by the current method. The research, presented today (8 September 2013) at the European Respiratory Society's Annual Congress in Barcelona, has provided evidence that each test could be used as an effective alternative to standard testing, increasing the possibilities open to clinicians. Drug...

2013-08-16 10:38:06

A new study has calculated the average cost per case of TB in the EU. The findings suggest the economic burden of TB far outweighs the costs of investing in more effective vaccines. The research, published online today (16 August 2013), in the European Respiratory Journal, is the first study to estimate the costs of the disease in recent years. Researchers used a systematic review of literature and institutional websites for the 27 EU member states to summarise economic data on the...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'